Clinical Trial Update: Topiramate Bioequivalence Study Brazil - Fast [Phase 1]

View source ↗

Summary

GlaxoSmithKline conducted a Phase 1 bioequivalence study of topiramate in Brazil, and the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy, Tonic-Clonic | Phase 1 | Status: COMPLETED